New players in cytokine control of HIV infection

被引：44

作者：

Alfano M. ^{[1
]}

Crotti A. ^{[1
]}

Vicenzi E. ^{[1
]}

Poli G. ^{[1
]}

机构：

[1] P2/P3 Laboratories, DIBIT, 20132, Milano

来源：

Current HIV/AIDS Reports | 2008年 / 5卷 / 1期

关键词：

Natural Killer Cell; Long Terminal Repeat; Lipodystrophy; Immunologic Dysregulation;

D O I：

10.1007/s11904-008-0005-5

中图分类号：

学科分类号：

摘要：

Cytokines are involved early in the pathogenesis of HIV infection and disease progression as a component of immunologic dysregulation and immunodeficiency and as determinants controlling virus replication. Several steps, before and after retroviral integration into host DNA in T cells and macrophages, are affected by cytokines whereas CCR5 and CXCR4 binding chemokines can interfere with viral entry. A growing number of potential players - including the γ-common interleukin (IL)-7, IL-15, and IL-21 together with IL-17, IL-18, IL-19, IL-20, IL-23, and IL-27 - are discussed in terms of their perturbation in HIV infection and of their effects on virus replication. Thus, an increasing intersection of HIV infection and the cytokine network represents a crucial determinant of virus replication and immunologic dysregulation and will likely play a key role in the development of effective strategies of HIV prevention and immunologic reconstitution. Copyright © 2008 by Current Medicine Group LLC.

引用

页码：27 / 32

页数：5

共 46 条

[31]

Lindegaard B., Hansen A.B., Pilegaard H., Et al., Adipose tissue expression of IL-18 and HIV-associated lipodystrophy, AIDS, 18, pp. 1956-1958, (2004)

[32]

Lindegaard B., Hansen A.B., Gerstoft J., Pedersen B.K., High plasma level of interleukin-18 in HIV-infected subjects with lipodystrophy, J Acquir Immune Defic Syndr, 36, pp. 588-593, (2004)

[33]

Falasca K., Manigrasso M.R., Racciatti D., Et al., Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients, Ann Clin Lab Sci, 36, pp. 59-66, (2006)

[34]

von Giesen H.J., Jander S., Koller H., Arendt G., Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease, J Neurovirol, 10, pp. 383-386, (2004)

[35]

Ahmad R., Sindhu S.T., Toma E., Et al., Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: Role of peripheral blood mononuclear cells and implications for AIDS pathogenesis, J Virol, 76, pp. 12448-12456, (2002)

[36]

Ahmad R., Iannello A., Samarani S., Et al., Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients, AIDS, 20, pp. 1907-1909, (2006)

[37]

Pugliese A., Vidotto V., Beltramo T., Torre D., Regulation of interleukin-18 by THP-1 monocytoid cells stimulated with HIV-1 and Nef viral protein, Eur Cytokine Netw, 16, pp. 186-190, (2005)

[38]

Shapiro L., Puren A.J., Barton H.A., Et al., Interleukin 18 stimulates HIV type 1 in monocytic cells, Proc Natl Acad Sci U S A, 95, pp. 12550-12555, (1998)

[39]

Torre D., Pugliese A., Speranza F., Et al., Role of interleukin-18 in human immunodeficiency virus type 1 infection, J Infect Dis, 185, pp. 998-999, (2002)

[40]

Choi H.J., Dinarello C.A., Shapiro L., Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells, J Infect Dis, 184, pp. 560-568, (2001)

← 1 2 3 4 5 →